Small interfering RNA (siRNA)

news

Boehringer Ingelheim agrees $2bn siRNA therapeutic collaboration

3 January 2024 | By Catherine Eckford (European Pharmaceutical Review)

The collaboration seeks to develop new siRNA treatments for the liver diseases nonalcoholic or metabolic dysfunction-associated steatohepatitis (NASH/MASH).

article

siRNA drug delivery across the blood-brain barrier in Alzheimer’s

24 October 2023 | By Carrie Taylor (BOC Sciences)

Carrie Taylor, Director of Research & Development at BOC Sciences examines the key pathologies in Alzheimer’s and highlights several promising siRNA drug delivery systems that offer potential in helping to overcome the neurodegenerative disease.

article

mRNA therapeutics: a limitless revolution in medicine

22 December 2022 | By Carsten Rudolph (Ethris) and Christian Plank (Ethris)

Carsten Rudolph and Christian Plank of Ethris, an mRNA therapeutics and vaccine‑focused German biotechnology company, discuss the current state of the art in the field, including delivery systems and administration of mRNA drug candidates to prevent or treat a plethora of diseases.

article

Drug Delivery In-Depth Focus 2022

21 December 2022 | By European Pharmaceutical Review

Articles explore the potential of tryptamines in treatment-resistant depression and drug delivery options for mRNA therapeutics.